Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development
Open Access
- 15 February 2006
- journal article
- Published by The Company of Biologists in Development
- Vol. 133 (4) , 663-673
- https://doi.org/10.1242/dev.02242
Abstract
Fibroblast growth factor receptor 1 (Fgfr1) plays pleiotropic roles during embryonic development, but the mechanisms by which this receptor signals in vivo have not previously been elucidated. Biochemical studies have implicated Fgf receptor-specific substrates (Frs2, Frs3) as the principal mediators of Fgfr1 signal transduction to the MAPK and PI3K pathways. To determine the developmental requirements for Fgfr1-Frs signaling, we generated mice (Fgfr1ΔFrs/ΔFrs) in which the Frs2/3-binding site on Fgfr1 is deleted. Fgfr1ΔFrs/ΔFrs embryos die during late embryogenesis, and exhibit defects in neural tube closure and in the development of the tail bud and pharyngeal arches. However, the mutant receptor is able to drive Fgfr1 functions during gastrulation and somitogenesis, and drives normal MAPK responses to Fgf. These findings indicate that Fgfr1 uses distinct signal transduction mechanisms in different developmental contexts, and that some essential functions of this receptor are mediated by Frs-independent signaling.Keywords
This publication has 64 references indexed in Scilit:
- FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial‐temporal patterns of expression of their transcriptsFEBS Letters, 2004
- Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell DevelopmentPLoS Biology, 2003
- The genetic basis of mammalian neurulationNature Reviews Genetics, 2003
- Evolutionary Divergence of Platelet-Derived Growth Factor Alpha Receptor Signaling MechanismsMolecular and Cellular Biology, 2003
- The Shb Adaptor Protein Binds to Tyrosine 766 in the FGFR-1 and Regulates the Ras/MEK/MAPK Pathway via FRS2 Phosphorylation in Endothelial CellsMolecular Biology of the Cell, 2002
- Coupling Met to Specific Pathways Results in Distinct Developmental OutcomesMolecular Cell, 2001
- Clinical spectrum of fibroblast growth factor receptor mutationsHuman Mutation, 1999
- Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred OncogeneHuman Gene Therapy, 1999
- SUC1-Associated Neurotrophic Factor Target (SNT) Protein Is a Major FGF-Stimulated Tyrosine Phosphorylated 90-kDa Protein Which Binds to the SH2 Domain of GRB2Biochemical and Biophysical Research Communications, 1996
- Expression and transforming activity of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the alpha exon at an alternate 3′-acceptor siteBiochemical and Biophysical Research Communications, 1992